People · Operator
Named in public records as an officer, director or promoter · active 2017–2023 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TripleBar Bio, Inc. | — | Biotechnology | Series B | $19.8M | $190.9M | 2023 |
| Phi Therapeutics, Inc. | — | Biotechnology | Series A | $8.9M | $74.4M | 2021 |
| Inside Out Medicine, Inc. | — | Other Health Care | Pre-Seed | $1.1M | $23.1M | 2017 |
Maria Cho at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Maria Cho on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Friedberg | 1 | 8 |
| Jun Li | 1 | 7 |
| KEVIN LAW | 1 | 3 |
| Howard Levin | 1 | 3 |
| NEIL GIUGNO | 1 | 1 |
| YUG VARMA | 1 | 1 |
| Maria S. Cho | 1 | 1 |
| Jun S. Li | 1 | 1 |
| Rose Wardle | 1 | 1 |
| HAO-TAM TRAN | 1 | 1 |
| ADAM GOLDIN | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.